Molecular Compatibility in Chinese Medicine for Cancer Treatment and Drug Development: From Traditional Wisdom to Innovative Therapeutics

ZHANG Ruo-nan; YOU Yu; GAO Quan; SUN Xue-ni; ZHENG Chuan; XIE Tian

doi:10.1007/s11655-025-4152-y

Your Location：

Home >

Browse articles >

Molecular Compatibility in Chinese Medicine for Cancer Treatment and Drug Development: From Traditional Wisdom to Innovative Therapeutics

Feature Article | Updated：2026-08-04

- Molecular Compatibility in Chinese Medicine for Cancer Treatment and Drug Development: From Traditional Wisdom to Innovative Therapeutics
- Chinese Journal of Integrative Medicine Vol. 32, Issue 2, Pages: 99-110(2026)
- Affiliations：
  
  1.School of Pharmacy, Hangzhou Normal University, Hangzhou(311121), China
  2.Zhejiang Provincial Key Laboratory of Anti-Cancer Chinese Medicines and Natural Medicines, Hangzhou(311121), China
  3.Engineering Research Center of Development and Application of Traditional Chinese Medicine from Zhejiang Province, Hangzhou (311121), China
  4.State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu(611137), China
  5.TCM Prevention and Treatment of Metabolic and Chronic Diseases Key Laboratory of Sichuan Province, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu (610072), China
  6.Sichuan Provincal Engineering Technology Research Center of Natural Small Molecule Drug, Tianfu TCM Innovation Harbour, Chengdu University of Traditional Chinese Medicine, Chengdu (611930), China
- Author bio：
  
  Prof. ZHENG Chuan, E-mail: zhengchuan@cdutcm.edu.cn;
  Prof. XIE Tian, E-mail: tianxie@hznu.edu.cn
- Funds：
- DOI：10.1007/s11655-025-4152-y
  CLC：
- Accepted：31 October 2025，
  
  Online First：09 December 2025，
  
  Published：2026-02
- Accepted：
Scan QR Code
ZHANG Ruo-nan, YOU Yu, GAO Quan, et al. Molecular Compatibility in Chinese Medicine for Cancer Treatment and Drug Development: From Traditional Wisdom to Innovative Therapeutics[J]. Chinese Journal of Integrative Medicine, 2026, 32(2): 99-110.
DOI：

ZHANG Ruo-nan, YOU Yu, GAO Quan, et al. Molecular Compatibility in Chinese Medicine for Cancer Treatment and Drug Development: From Traditional Wisdom to Innovative Therapeutics[J]. Chinese Journal of Integrative Medicine, 2026, 32(2): 99-110. DOI： 10.1007/s11655-025-4152-y.

摘要

Abstract

关键词

Keywords

references

Views

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

Berberine Regulates Hepatic Fatty Acid Metabolism via AMPK/SIRT1/PGC-1α Pathway

Effect and Mechanisms of Electroacupuncture on Mucosal Healing in Ulcerative Colitis Mice via Non-neuroronal Cholinergic System

Loganin Alleviates CCl4-Induced Acute Liver Injury by Promoting Mitophagy and Inhibiting NLRP3 Inflammasome

Lianxia Xiaopi Granules for Treatment of Functional Dyspepsia: A Multicenter, Randomized, Double-Blind and Placebo-Controlled Trial

Transcutaneous Electrical Acupoint Stimulation Reduces Postoperative Abdominal Pain after Endoscopic Submucosal Dissection: A Single-Center, Prospective, and Randomized Controlled Trial

Related Author

No data

Related Institution

No data

Address：1 Caochang, xiyuan, Beijing, People's Republic of China Postal code：100091
Tel：010-62886827, 62877592 Fax：010-62874291
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备05067934号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰